within Pharmacolibrary.Drugs.ATC.B;

model B05XA10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.3333333333333333,
    adminDuration  = 600,
    adminMass      = 2.0,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium phosphate is an inorganic salt of magnesium used primarily as an electrolyte replenisher in parenteral nutrition and to treat hypomagnesemia. It is not commonly administered as a drug by itself but rather as a component of intravenous fluids or oral supplements. Currently, its use is primarily supportive in electrolyte management.</p><h4>Pharmacokinetics</h4><p>No human pharmacokinetic studies are available that specifically detail the pharmacokinetics of magnesium phosphate as an independent drug. Parameters are estimated based on pharmacokinetics of magnesium salts administered intravenously or orally in healthy adults.</p><h4>References</h4><ol><li><p>Wilimzig, C, et al., &amp; Nyulassy, S (1996). Increase in magnesium plasma level after orally administered trimagnesium dicitrate. <i>European journal of clinical pharmacology</i> 49(4) 317–323. DOI:<a href=&quot;https://doi.org/10.1007/BF00226334&quot;>10.1007/BF00226334</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8857079/&quot;>https://pubmed.ncbi.nlm.nih.gov/8857079</a></p></li><li><p>Jacobsen, O, et al., &amp; Jarnum, S (1986). Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. <i>Scandinavian journal of gastroenterology</i> 21(7) 824–828. DOI:<a href=&quot;https://doi.org/10.3109/00365528609011125&quot;>10.3109/00365528609011125</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3095911/&quot;>https://pubmed.ncbi.nlm.nih.gov/3095911</a></p></li><li><p>Lanvers-Kaminsky, C, et al., &amp; Boos, J (2006). Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. <i>Pediatric blood &amp; cancer</i> 47(2) 183–193. DOI:<a href=&quot;https://doi.org/10.1002/pbc.20673&quot;>10.1002/pbc.20673</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16302218/&quot;>https://pubmed.ncbi.nlm.nih.gov/16302218</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05XA10;
